PIG-1 MELK-dependent phosphorylation of nonmuscle myosin II promotes apoptosis through CES-1 Snail partitioning
Authors:
Hai Wei aff001; Eric J. Lambie aff001; Daniel S. Osório aff003; Ana X. Carvalho aff003; Barbara Conradt aff001
Authors place of work:
Department Biology II, Faculty of Biology, Ludwig-Maximilians-University Munich, Großhadener, Planegg-Martinsried, Germany
aff001; Research Department of Cell and Developmental Biology, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, United Kingdom
aff002; Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal
aff003; CIPSM–Center for Integrated Protein Science Munich, Butenandtstraße, München, Germany
aff004
Published in the journal:
PIG-1 MELK-dependent phosphorylation of nonmuscle myosin II promotes apoptosis through CES-1 Snail partitioning. PLoS Genet 16(9): e32767. doi:10.1371/journal.pgen.1008912
Category:
Research Article
doi:
https://doi.org/10.1371/journal.pgen.1008912
Summary
The mechanism(s) through which mammalian kinase MELK promotes tumorigenesis is not understood. We find that the C. elegans orthologue of MELK, PIG-1, promotes apoptosis by partitioning an anti-apoptotic factor. The C. elegans NSM neuroblast divides to produce a larger cell that differentiates into a neuron and a smaller cell that dies. We find that in this context, PIG-1 MELK is required for partitioning of CES-1 Snail, a transcriptional repressor of the pro-apoptotic gene egl-1 BH3-only. pig-1 MELK is controlled by both a ces-1 Snail- and par-4 LKB1-dependent pathway, and may act through phosphorylation and cortical enrichment of nonmuscle myosin II prior to neuroblast division. We propose that pig-1 MELK-induced local contractility of the actomyosin network plays a conserved role in the acquisition of the apoptotic fate. Our work also uncovers an auto-regulatory loop through which ces-1 Snail controls its own activity through the formation of a gradient of CES-1 Snail protein.
Keywords:
Cell cycle and cell division – Caenorhabditis elegans – Fluorescence imaging – Phosphorylation – Metaphase – Myosins – Neuroblasts
Introduction
Mammalian ‘Maternal Embryonic Leucine zipper Kinase’ referred to as MELK was identified in 1997 using two different approaches. Using differential cDNA display, transcripts of the MELK gene were identified in early mouse embryos and shown to be maternally expressed [1]. Transcripts of the same gene (initially referred to as MPK38) were also identified using a PCR-based screen for new kinase genes expressed in a murine teratocarcinoma cell line [2]. The MELK gene encodes a member of the family of AMPK (AMP-activated protein kinase) -related serine/threonine protein kinases and has orthologues in species as diverse as C. elegans and humans [3]. Vertebrate MELK kinase has been implicated in a broad range of cellular processes such as cell division, cell death and survival, cellular differentiation and embryonic development, and many of the proposed functions appear to be context-dependent. Therefore, it has been suggested that MELK may affect various aspects of cell fate acquisition [3–5]. This is supported by the finding that MELK can affect gene expression through physical interactions with transcription factors and regulators of protein synthesis [6–8]. Furthermore, through its interaction with the scaffold protein Arrestin 3, MELK protein may act in signaling cascades that are restricted to certain subcellular regions [5]. The MELK gene is overexpressed in different types of cancers, including ‘triple negative’ breast cancer (TNBC), the most aggressive form of this type [9]. Importantly, it was recently demonstrated that MELK function is required for clonogenic growth of TNBC-derived cells, and this has made MELK a target for the development of novel cancer therapeutics [10–13]. However, the physiological function(s) of MELK and the mechanism(s) through which its overexpression contributes to tumorigenesis remain largely unknown.
The C. elegans orthologue of the MELK gene, pig-1, was identified in several independent genetic screens and subsequent analyses have implicated pig-1 in asymmetric cell division and programmed cell elimination. Originally, the pig-1 gene was identified in a screen for mutations that alter the numbers of two specific types of neurons, the HSN and PHB neurons, and was subsequently found to affect the asymmetric division of the HSN/PHB neuroblast in larvae of the first larval stage (L1 larvae) [14]. The HSN/PHB neuroblast normally divides asymmetrically to give rise to a larger cell that divides to generate one HSN and one PHB neuron and a smaller cell that undergoes apoptosis [15]. In pig-1 mutants, the HSN/PHB neuroblast divides symmetrically to give rise to two cells of similar sizes, both of which survive and can divide to give rise to a total of two HSNs and two PHBs [14]. Subsequent analyses in early C. elegans embryos confirmed a role for pig-1 in asymmetric cell division and demonstrated that this function is not specific to cell divisions that give rise to an apoptotic death [16–18]. Furthermore, in this context, pig-1 was found to act in a pathway that is redundant with a pathway that is dependent on the gene par-1, which encodes a serine/threonine kinase similar to PIG-1 [16]. Several observations suggest that pig-1 acts in asymmetric cell division by controlling the distribution of nonmuscle myosin II NMY-2 in dividing cells [18, 19]. However, the mechanism(s) through which pig-1 MELK affects NMY-2 distribution remains unknown. pig-1 was furthermore identified in a screen for mutations that prevent the shedding or extrusion of inappropriately surviving ‘undead’ cells from the embryo proper in mutants that lack the caspase gene ced-3 and in a screen for mutations that block the ced-3 caspase-dependent apoptotic death of specific cells during development [20, 21]. Based on this it was proposed that pig-1 MELK is a component of a ‘programmed cell elimination’ pathway that acts in parallel to the canonical ced-3 caspase-dependent apoptosis pathway to ensure that specific cells are reproducibly removed during C. elegans development. Finally, mammalian AMPK-related kinases are activated through phosphorylation by the kinase LKB1 at a conserved threonine residue and this is dependent on the LKB1 binding partners STRADα and MO25α [22]. The loss of C. elegans par-4, strd-1 or mop-25.1, 2, which encode C. elegans homologs of LKB1, STRADα and MO25α, respectively, phenocopies the loss of pig-1 in the context of both asymmetric cell division and programmed cell elimination [20, 23], indicating that the activity of PIG-1 MELK could be dependent on PAR-4 LKB1-dependent PIG-1 phosphorylation.
Here we study one specific apoptotic death during C. elegans development, the death of the two Neuro-Secretory Motorneuron (NSM) sister cells in the NSM neuroblast lineage. The two NSM neuroblasts (NSMnb) divide to each give rise to a larger cell, the NSM, which differentiates into a serotonergic neuron, and a smaller cell, the NSM sister cell (NSMsc), which dies through apoptosis [15]. The C. elegans gene ces-1 encodes a zinc-finger DNA binding protein and member of the family of Snail-like transcription factors. A dominant mutation in a cis-regulatory region of the ces-1 gene (n703) referred to as ces-1 ‘gain-of-function’ (gf) mutation causes the overexpression of the gene in the NSMnb and this results in symmetric NSMnb division and the generation of two cells of similar sizes, both of which survive and differentiate into NSM-like neurons [24–26]. We have previously shown that the pig-1 MELK gene is a direct transcriptional target of CES-1 Snail and that the ces-1 gf mutation affects asymmetric NSMnb division by repressing pig-1 expression in the NSMnb [27]. We now demonstrate that pig-1 activity in the NSM neuroblast lineage is also controlled through the par-4 LKB1, strd-1 STRADα and mop-25.1, 2 MO25α-dependent pathway. In addition, we present evidence that pig-1 MELK-dependent phosphorylation of nonmuscle myosin II NMY-2 is required for asymmetric cortical enrichment of NMY-2 in the NSMnb and the generation, during NSMnb division, of differently-sized cells. Furthermore, pig-1 MELK and nmy-2 nonmuscle myosin II are also required for the establishment or maintenance of a gradient of CES-1 Snail protein in the NSMnb and the partitioning of CES-1 protein into the larger daughter cell, the NSM. Our results suggest that the resulting lower concentration of CES-1 Snail protein in the NSMsc contributes to the rapid kinetics with which the pro-apoptotic BH3-only gene egl-1 (the transcription of which is directly repressed by CES-1 Snail) is transcriptionally upregulated and apoptotic cell death is executed in the NSMsc. Hence, our results suggest that in the NSM neuroblast lineage, pig-1 MELK- and nmy-2 nonmuscle myosin II-dependent cortical contractility of the actomyosin network is critical not only for daughter cell size asymmetry but the acquisition of the apoptotic fate.
Results
pig-1 MELK may act with par-4 LKB1, strd-1 STRADα and mop-25.1, .2 MO25α to control daughter cell size asymmetry in the NSM neuroblast lineage
In wild-type animals, the NSM neuroblast (NSMnb) divides asymmetrically by size to give rise to a smaller cell, the NSM sister cell (NSMsc), and a larger cell, the NSM, with a cell volume ratio of NSMsc to NSM of about 0.64 as measured using a transgene that expresses a mCherry fusion protein that localizes to the plasma membrane and, hence, allows the visualization of cell boundaries (Ppie-1mCherry::ph PLCδ) [25] (Fig 1A and 1B). We previously showed that in animals homozygous for the strong pig-1 loss-of-function (lf) mutation gm344, the NSMnb divides symmetrically with a cell volume ratio of NSMsc to NSM of about 1.00 [27] (Fig 1; S1 Fig). It has been shown that in other cellular contexts, pig-1 MELK acts in a pathway with par-4 LKB1, strd-1 STRADα and mop-25.1, .2 MO25α [20, 23]. (Denning et al., 2012 demonstrated that mop-25.1 and mop-25.2 are functionally redundant. For this reason, we inactivated the two genes simultaneously.) Using the temperature-sensitive (ts) par-4 loss-of-function (lf) mutation it57ts, the strd-1 lf mutation ok2283 and RNA-mediated interference (RNAi) against mop-25.1 and mop-25.2 in the background of the mop-25.2 lf mutation ok2073 (RNAi[mop-25.1+mop-25.2] in mop-25.2[ok2073]), we found that the loss of par-4, strd-1 or mop-25.1, .2 causes the NSMnb to divide symmetrically by size as well (Fig 1C; S1 Fig). Furthermore, we found that the simultaneous loss of pig-1 and strd-1 causes a phenotype that is not different from the phenotypes observed in the single mutants. These results indicate that par-4 LKB1, strd-1 STRADα and mop-25.1, .2 MO25α are required for daughter cell size asymmetry in the NSM neuroblast lineage and that in this context, they may act in the same pathway as pig-1 MELK.
pig-1 MELK acts with par-4 LKB1, strd-1 STRADα and mop-25.1, .2 MO25α to promote the death of the NSM sister cell
In wild-type animals, the NSMsc dies shortly after being generated and this results in one NSM neuron on each side of the anterior pharynx as shown in larvae of the L3 or L4 stage using a transgene that expresses a nuclear-localized GFP fusion protein in the NSM neuroblast lineage (Ptph-1his-24::gfp) [28] (Fig 2A and 2B). We previously showed that pig-1(gm344) causes about 2% of the NSMsc to inappropriately survive with the affected animals exhibiting more than two NSM-like cells in the anterior pharynx (Fig 2B) and that NSMsc survival increases to about 30% in the background of a weak ced-3 lf mutation, n2427 [27] (Fig 2C). We now find that par-4(it57ts), strd-1(ok2283) or RNAi(mop-25.1+mop-25.2) in mop-25.2(ok2073) also causes about 2% NSMsc survival in a wild-type and about 30% NSMsc survival in the ced-3(n2427) background (Fig 2C). Furthermore, the loss of strd-1 in pig-1(gm344) mutants does not further enhance NSMsc survival in the wild-type or ced-3(n2427) background.
In C. elegans, cell corpses adopt a refractile morphology, which can be visualized by Nomarski Optics [29]. In wild-type animals, the NSMsc becomes refractile about 22 min after being generated (Fig 3A, 3B and 3C; S2 Fig). We previously showed that in pig-1(gm344) mutants, the NSMsc takes about 30 min to become refractile, suggesting a delay in cell death [27] (Fig 3C). We find a similar delay in animals lacking par-4, strd-1 or mop-25.1, .2. Furthermore, in animals lacking both pig-1 and strd-1, this delay is not increased (Fig 3C). Taken together, these results indicate that par-4 LKB1, strd-1 STRADα, mop-25.1, .2 MO25α and pig-1 MELK act in the same genetic pathway to promote the death of the NSMsc.
Loss of pig-1 MELK causes delayed transcriptional upregulation of the BH3-only gene egl-1 in the NSM sister cell
The NSMsc dies through apoptotic cell death [30]. A hallmark of apoptosis during C. elegans development is the transcriptional upregulation in cells ‘programmed’ to die of the gene egl-1, which encodes a pro-apoptotic member of the Bcl-2 family of proteins (a BH3-only protein) [31–33]. To determine whether the loss of pig-1 MELK blocks or delays the death of the NSMsc by compromising the transcriptional upregulation of egl-1 BH3-only, we used a multi-copy transgene of a transcriptional egl-1 reporter (Pegl-1his-24::gfp) [34] to analyze the kinetics of egl-1 expression in the NSMsc starting immediately after the completion of NSMnb division (0 min post NSMnb division). In wild-type animals, egl-1 expression becomes detectable about 12 min post NSMnb division at which time point its expression (as measured by fluorescence intensity per area in a focal plane through the center of the NSMsc) is increased 2-fold above baseline (Fig 4A and 4B; S3 Fig). Hence, egl-1 expression becomes detectable 10 min prior to the death of the NSMsc at 22 min. We found that in pig-1(gm344) mutants, egl-1 expression reaches a level that is 2-fold above baseline about 22 min post NSMnb division, which is 12 min prior to the death of the NSMsc at 34 min. Therefore, the loss of pig-1 MELK causes a delay in the transcriptional upregulation of egl-1 BH3-only in the NSMsc and this delay correlates with the delay observed in the execution of the NSMsc death.
Formation of a CES-1 Snail gradient in the NSM neuroblast and partitioning of CES-1 Snail into the NSM during NSM neuroblast division
egl-1 BH3-only transcription in the NSMnb lineage can directly be repressed by the Snail-like transcription factor CES-1 [26, 34]. To visualize CES-1 protein in the NSM neuroblast lineage in real time, we generated a single-copy transgene of a translational ces-1 reporter that produces a CES-1::mNeonGreen fusion protein under the control of the endogenous ces-1 promoter (Pces-1ces-1::mNeonGreen). This transgene is functional as it rescues a putative ces-1 null mutation, tm1036 (S4 Fig). In animals carrying this transgene, CES-1 is detectable in the NSMnb, the NSM and the NSMsc. In the NSMnb, signal is detectable at similar levels throughout the cell about 5 min before it enters metaphase (Fig 5A, +/+, [Before NSMnb division: ~5 min before]). This is confirmed by measuring, in overlapping steps, total fluorescence intensity per area along the dorsal-ventral axis in the representative cell and focal plane shown in Fig 5A (Fig 5B, +/+). In contrast, once the NSMnb enters metaphase (as indicated by the distinctive rounding up of the cell), a gradient of signal is detectable with increasing signal from the dorsal to the ventral side (Fig 5A, +/+, [Before NSMnb division: metaphase]; Fig 5C, +/+). (The dorsal side will form the NSMsc and the ventral side the NSM.) This gradient results in a ratio of CES-1 in the ventral half of the NSMnb to the dorsal half of 1.45 (Fig 5D, +/+, [Before NSMnb division: Metaphase]). Furthermore, after NSMnb division, less CES-1 is detectable in the NSMsc compared to the NSM (Fig 5A, +/+, [Post NSMnb division: NSMsc, NSM]) with a ratio of CES-1 in the NSM to the NSMsc of 1.51 (Fig 5D, +/+, [Post NSMnb division: NSM/NSMsc]). Based on these results we conclude that prior to NSMnb division, a gradient of CES-1 Snail protein is formed in the NSMnb and that this gradient results in the partitioning of CES-1 Snail predominantly into the NSM.
pig-1 MELK but not ced-1 MEGF10 is required for CES-1 Snail gradient
The bZIP transcription factor CES-2 is orthologous to human DBP (D-box binding PAR bZIP transcription factor) and is thought to directly repress the transcription of the ces-1 Snail gene in the NSM neuroblast lineage by binding to the cis-acting element that is mutated in animals carrying the ces-1 gf mutation [24, 26, 35]. Indeed, the loss of ces-2 recapitulates the phenotype of ces-1 gf animals in the NSM neuroblast lineage [24–27]. Furthermore, using the Pces-1ces-1::mNeonGreen reporter, we observe increased levels of CES-1 Snail protein in the NSM neuroblast lineage of animals lacking ces-2 function (Fig 5A, ces-2(bc213)). Importantly, CES-1 protein does not only contribute to the repression of egl-1 BH3-only transcription in the NSM but also to the polarization and asymmetric division of the NSMnb [25, 27]. For this reason, in animals homozygous for the strong ces-2 lf mutation bc213, increased levels of CES-1 protein in the NSM neuroblast lineage cause the NSMnb to divide symmetrically, resulting in two cells of similar sizes and fates [25]. We find that in this case, there is also no CES-1 gradient detectable in the NSMnb at metaphase and CES-1 is equally segregated into the NSM and NSMsc with a ratio of CES-1 in the NSM to the NSMsc of 0.97 (Fig 5A–5D, ces-2(bc213)). Furthermore, we previously showed that a low level of CED-3 caspase activity exists in the NSMnb prior to division; this activity is distributed in a gradient that is reciprocal to that of CES-1 Snail protein, i.e., with a higher level of CED-3 caspase activity in the dorsal part of the NSMnb and a lower level in the ventral part [36, 37]. In addition, we demonstrated that the formation and/or maintenance of this gradient is dependent on components of the two C. elegans engulfment pathways, for example the gene ced-1, which encodes a MEGF10-like scavenger receptor that in this context acts most likely in cells adjacent to the NSMnb [36, 38, 39]. To test whether the CES-1 Snail gradient is also dependent on components of the engulfment pathways, we analyzed animals homozygous for the strong ced-1 lf mutation e1735. We found that the loss of ced-1 has no effect on the formation of the CES-1 gradient in the NSMnb or the partitioning of CES-1 into the NSM (Fig 5, ced-1(e1735)).
Next, we tested animals lacking pig-1 MELK or strd-1 STRADα and found that while levels of CES-1 protein appear unaffected in these animals, no CES-1 gradient is detectable in the NSMnb at metaphase (ratios of CES-1 in the ventral to dorsal side of the NSMnb of 1.04 or 1.05, respectively) and the amount of CES-1 segregated into both daughter cells is similar (ratios of CES-1 in the NSM to NSMsc of 1.01 or 0.99, respectively) (Fig 5, pig-1(gm344), strd-1(ok2283)). In summary, these results suggest that the formation of the CES-1 Snail gradient and the partitioning of CES-1 Snail into the NSM require pig-1 MELK and are under the control of both a ces-2 DBP, ces-1 Snail- and par-4 LKB1, strd-1 STRADα, mop-25.1, .2 MO25α-dependent pathway, but not a ced-1 MEGF10-dependent pathway.
pig-1 MELK is required for the enrichment of nonmuscle myosin II NMY-2 on the cell cortex of the ventral side of the NSM neuroblast prior to its division
The C. elegans nonmuscle myosin II NMY-2 has been proposed to be a target of PIG-1 MELK [19, 40]. Furthermore, NMY-2 phosphorylation at two specific residues, serine 211 (S211) and serine 1974 (S1974), was found to be reduced in pig-1 mutants [41]. Using a nmy-2 CRISPR knock-in allele that produces a functional NMY-2::GFP fusion protein (nmy-2(cp13), nmy-2::gfp+LoxP) [42], we visualized NMY-2 in the NSMnb. We found that starting about 10 min before NSMnb metaphase, NMY-2 becomes enriched on the cell cortex of the ventral side of the NSMnb and this enrichment is maintained through metaphase (Fig 6A; S5 Fig, +/+). We confirmed this enrichment by measuring, in overlapping steps, fluorescence intensity per area along the dorsal-ventral axis in the representative cell and focal plane shown in Fig 6A (Fig 6B and 6C, +/+). In addition, we measured fluorescence intensities in the dorsal and ventral half of the NSMnb and determined their ratio. This revealed that about 5 min before NSMnb metaphase or at metaphase, there is 1.88-fold or 1.67-fold more NMY-2 in the ventral half of the NSMnb compared to its dorsal half, respectively (Fig 6D, +/+). Since NMY-2 has been proposed to be a target of PIG-1 MELK, next, we analyzed pig-1(gm344) animals and found that the enrichment of NMY-2 on the cell cortex of the ventral side about 5 min before NSMnb division or at metaphase is almost abolished with ratios of NMY-2 in ventral to dorsal halves of NSMnb of 1.18 or 1.07, respectively (Fig 6A–6D, pig-1(gm344)). In contrast, the enrichment of NMY-2 at the cleavage furrow is unaffected in pig-1(gm344) animals (S5A Fig, pig-1(gm344)). Therefore, nonmuscle myosin II NMY-2 becomes enriched on the cell cortex of the ventral side of the NSMnb prior to its division and this enrichment is dependent on pig-1 MELK. We also noted a slight, statistically not significant decrease in total fluorescence intensity of NMY-2::GFP in the NSMnb but not the entire embryo, which suggests that the loss of pig-1 may also affect the turn-over of NMY-2 protein in the NSM neuroblast lineage (S6 Fig).
nmy-2 nonmuscle myosin II acts downstream of pig-1 MELK to control cell size, partitioning of CES-1 Snail into the NSM, and NSM sister cell death
To determine whether nmy-2 nonmuscle myosin II plays a role in the asymmetric division of the NSMnb, we analyzed animals homozygous for the temperature-sensitive nmy-2 lf mutation ne3409ts. At the non-permissive temperature of 25°C, nmy-2(ne3409ts) causes 100% embryonic lethality (Emb phenotype) (S7 Fig). Therefore, we allowed nmy-2(ne3409ts) embryos to develop at the permissive temperature and shifted them to 25°C 15 min before NSMnb division. We found that the loss of nmy-2 causes a phenotype that is indistinguishable from that of pig-1 mutants. Specifically, in nmy-2(ne3409ts) animals, the NSMnb divides symmetrically by size (Fig 1C; S1 Fig), 2.1% of the NSMsc survive (Fig 2C), cell death in the NSMsc is delayed (Fig 3C; S2 Fig), and the formation of the CES-1 Snail gradient in the NSMnb and CES-1 partitioning into the NSM are disrupted (Fig 5). Furthermore, the defects in nmy-2(ne3409ts) animals in daughter cell sizes (Fig 1C; S1 Fig) and NSMsc death (Fig 2C; Fig 3C; S2 Fig) are not enhanced by the simultaneous loss of pig-1. This suggests that in the context of the NSM neuroblast lineage, pig-1 MELK and nmy-2 nonmuscle myosin II act in the same genetic pathway.
As mentioned above, phosphorylation of NMY-2 protein at S211 and S1974 is reduced in pig-1 MELK mutants. To determine whether phosphorylation at these two residues plays a role in the NSM neuroblast lineage, we generated nmy-2 transgenes that mediate the expression of wild-type NMY-2 protein (referred to as NMY-2(S)) or mutant NMY-2 protein in which S211 and S1974 are replaced with non-phosphorylatable alanines (NMY-2(S-A)) or phospho-mimetic aspartic acids (NMY-2 (S-D)) (S8A Fig). First we analyzed these transgenes for their abilities to rescue the Emb phenotype caused by nmy-2(ne3409ts) at 25°C and found that the nmy-2(S) and nmy-2(S-D) transgenes rescue the phenotype by 94% or 86%, respectively, whereas the nmy-2(S-A) transgene rescues it only by 24% (S7 Fig). This indicates that phosphorylation at S211 and S1974 is critical for the essential function(s) of NMY-2 in embryogenesis.
In embryos rescued from lethality, we then analyzed the NSM neuroblast lineage and found that the defects in daughter cell sizes and cell death in nmy-2(ne3409ts) mutants are rescued by the wild-type nmy-2(S) and phospho-mimetic nmy-2(S-D) transgenes but not the non-phosphorylatable nmy-2(S-A) transgene (Fig 1C; Fig 3C). This suggests that phosphorylation of nonmuscle myosin II NMY-2 at these two residues is also critical for the ability of NMY-2 to cause asymmetric NSMnb division and to promote NSMsc death.
Finally, we tested the nmy-2 transgenes for their abilities to rescue the loss of pig-1 MELK in the context of the NSM neuroblast lineage. We found that the wild-type nmy-2(S) transgene and the non-phosphorylatable nmy-2(S-A) transgene fail to rescue the defects in daughter cell size asymmetry and NSMsc death in pig-1(gm344) mutants (Fig 1C; Fig 3C). In contrast, the phospho-mimetic nmy-2(S-D) transgene partially rescues the defect in daughter cell sizes (Fig 1C) and fully rescues the defect in NSMsc death (Fig 3C). Based on these findings, we propose that nmy-2 nonmuscle myosin II acts downstream of pig-1 MELK to cause asymmetric NSMnb division and that PIG-1 MELK-dependent phosphorylation at S211 and S1974 is critical for NMY-2 function in this context.
Discussion
Roles for actomyosin network in NSM neuroblast division
We present evidence in support of the notion that pig-1 MELK controls daughter cell size asymmetry and CES-1 Snail gradient formation in the NSM neuroblast lineage by directly or indirectly causing the phosphorylation at S211 and S1974 of nonmuscle myosin II NMY-2 (Fig 7A). PIG-1 is structurally and functionally similar to the C. elegans kinase PAR-1 [16], which has been shown to physically interact with NMY-2 [40]. Therefore, we consider it likely that PIG-1 directly interacts with and phosphorylates NMY-2. Our data also suggest that pig-1-dependent phosphorylation of NMY-2 causes or maintains the enrichment of NMY-2 on the cell cortex on the ventral side of the NSMnb that occurs prior to NSMnb division. Whether PIG-1 protein itself is enriched in this part of the NSMnb is currently not known. Asymmetric cortical enrichment of myosin can cause long-range intracellular flows and asymmetric cortical contractility of the actomyosin network [43–46]. Therefore, we propose that the asymmetric cortical enrichment of NMY-2 in the NSMnb results in flows directed towards the ventral side and increased cortical contractility on the ventral side (Fig 7B). How intracellular protein gradients, such as the CES-1 Snail gradient described here, are established is not fully understood. Studies of the one-cell C. elegans embryo suggest that diffusion-state switching and long-range cortical flows can generate stable protein gradients [47–52]. Furthermore, asymmetric cortical contractility and local cortical extension have been shown to contribute to the partitioning of proteins during the asymmetric divisions of D. melanogaster neuroblasts [43, 53, 54]. Therefore, we propose that the establishment in the NSMnb of the dorsal-ventral gradient of CES-1 Snail protein is caused through pig-1 MELK- and nmy-2 nonmuscle myosin II-dependent directed flows and/or asymmetric cortical contractility. How this is coordinated with other events that occur just prior to the actual NSMnb division, such as nuclear envelop breakdown, is currently unknown. During certain asymmetric cell divisions, such as the division of the QR neuroblast in C. elegans L1 larvae or the divisions of neuroblasts in D. melanogaster, asymmetric cortical contractility and extension have been shown to determine cleavage furrow placement and, hence, daughter cell sizes, in a spindle-independent manner [19, 54–56]. Therefore, we furthermore propose that the pig-1 MELK- and nmy-2 nonmuscle myosin II-dependent cortical contractility on the ventral side of the NSMnb also determines the position of the cleavage furrow and, hence, the sizes of the NSM and NSMsc. Whether this occurs through a spindle-independent mechanism remains to be determined.
Roles for CES-1 Snail partitioning and cell size control in life vs death decision
We propose that the partitioning of CES-1 Snail into the NSM contributes to the life vs death decision in the NSM neuroblast lineage. By binding to four conserved Snail binding elements (SBEs) downstream of the egl-1 BH3-only transcription unit, CES-1 can directly repress egl-1 transcription [34] (Fig 7B). We propose that the partitioning of CES-1 protein into the NSM results in a concentration of CES-1 in the NSM that is sufficient to bind to the four SBEs and repress egl-1. In contrast, the concentration of CES-1 in the NSMsc is not sufficient to repress egl-1, resulting in the detection of egl-1 expression 12 min post NSMnb division. We found that in animals lacking pig-1 MELK function, the NSM and NSMsc are of similar sizes and inherit similar amounts of CES-1 Snail protein. Despite its smaller cell size and reduced amounts of CES-1 protein inherited, the NSM still survives, suggesting that the concentration of CES-1 remains high enough to repress egl-1 transcription. In the NSMsc, its larger cell size and increased amounts of CES-1 protein lead to a delay in egl-1 expression and cell death execution by about 10 min. In 98% of the cases, the cell still dies; however, the amount of EGL-1 that has accumulated at the time of death (based on reporter gene expression) is significantly higher compared to wild type, suggesting that cell death execution in these cells is compromised. In animals that lack ces-2 DBP function, the NSM and NSMsc are of similar sizes [25] and inherit similar amounts of CES-1 Snail protein. However, in ces-2 mutants, the death of the NSMsc is blocked [24]. Therefore, there is a functional difference between the NSMsc in pig-1 and ces-2 mutants with respect to their propensities to die. As shown in Fig 5A, the level of CES-1 Snail protein in the NSM neuroblast lineage is increased several-fold in ces-2 mutants compared to wild type or pig-1 mutants. This increased level of CES-1 could explain the difference with respect to NSMsc survival between pig-1 and ces-2 mutants. However, additional factors that affect egl-1 transcription and/or cell death execution may also contribute. For example, a heterodimer of the bHLH proteins HLH-2 and HLH-3 (HLH-2/HLH-3) activates egl-1 transcription in the NSM neuroblast lineage by competing with CES-1 Snail for binding to the SBEs [34] (Fig 7B). If the partitioning and/or activity of HLH-2/HLH-3 were affected in either ces-2 or pig-1 mutants, a difference in the ability of CES-1 Snail protein to repress egl-1 transcription in the NSMsc might be observed. Furthermore, a gradient of active CED-3 caspase is formed in the NSM neuroblast and this gradient results in the partitioning of active CED-3 predominantly into the NSMsc, where it promotes cell death execution [36]. The loss of ces-2, but not pig-1, abolishes the formation of this gradient [36, 38]. Consequently, cell death execution most likely is compromised in the NSMsc in ces-2, but not pig-1 mutants. In conclusion, we consider it likely that factors other than CES-1 Snail contribute to the life vs death decision in the NSM neuroblast lineage, and our results suggest that the activities of these factors may be independent of cell size. However, since we cannot manipulate daughter cell sizes in the NSM neuroblast lineage without affecting levels and/or partitioning of CES-1 Snail protein, we are currently unable to determine their relative contributions.
A CES-1 Snail auto-regulatory loop
We demonstrate that ces-1 Snail can control its own activity by inducing the formation of a gradient of CES-1 protein prior to cell division, which then results in the inheritance of different amounts of CES-1 by the two daughter cells. To our knowledge, this is the first time such a mechanism has been described for a member of the Snail family of transcription factors. This auto-regulatory loop depends on the ability of the CES-1 Snail transcription factor to control the expression of the pig-1 MELK gene, the phosphorylation of nonmuscle myosin II NMY-2 through the kinase PIG-1, and the NMY-2-dependent formation of a gradient of CES-1 protein. The nmy-2 gene may also be a direct transcriptional target of CES-1 [27], which suggests that CES-1 might control the expression of several components of this regulatory loop. Furthermore, we have previously shown that by controlling the expression of the gene cdc-25.2 CDC25, CES-1 Snail can slow cell cycle progression in the NSM neuroblast lineage [28], and this may provide the time necessary for the completion of the regulatory loop, i.e. the formation of the CES-1 gradient.
The auto-regulatory loop of ces-1 Snail causes its activity to differ in the three different cells of the NSM neuroblast lineage, with the highest activity in the NSM and the lowest in the NSMsc (assuming that the total amount of CES-1 protein in the lineage remains constant). Importantly, this may cause differences in CES-1 target gene selection and, hence, ces-1 function between these cells. Snail-like transcription factors were originally identified based on their conserved roles in epithelial-mesenchymal transitions (EMTs) [57]. However, more recently, they have also been implicated in various aspects of stem cell biology and function [58, 59]. Interestingly, studies of intestinal stem cell lineages in both D. melanogaster and mouse have revealed that the roles of Snail-like transcription factors in stem cells are complex and involve important functions in both stem cell maintenance and daughter cell fate specification. We speculate that auto-regulatory loops similar to the one described here for C. elegans CES-1 Snail may contribute to the complex roles of Snail-like transcription factors in stem cell lineages in other organisms.
Regulation and functions of MELK
We confirm previous reports that in C. elegans, the genes pig-1 MELK and par-4 LKB1 act in the same genetic pathway [20, 23]. Therefore, C. elegans PIG-1 MELK is probably activated through PAR-4 LKB1-dependent phosphorylation. Hence, in the NSM neuroblast lineage, pig-1 MELK activity is controlled at the level of gene expression through ces-1 Snail-dependent transcriptional repression [27] and at the post-translational level through par-4 LKB1-dependent protein phosphorylation.
The role of C. elegans pig-1 MELK in asymmetric cell division is well established. We present evidence that in this context, PIG-1 MELK kinase acts through the phosphorylation of NYM-2 nonmuscle myosin II. NMY-2 activity then determines the sizes of the resulting daughter cells and the partitioning of one or more factors that contribute to the acquisition of the appropriate fates by the daughter cells. It has been suggested that C. elegans pig-1 MELK is also required for 'programmed cell elimination' [20, 21], i.e., the extrusion of inappropriately surviving cells from embryos that lack ced-3 caspase activity. Based on the data presented here, the ‘undead’ cells present in pig-1 MELK mutants are not only larger in size but also inherit important factors that they normally would not (e.g., CES-1 Snail, in the case of the NSM neuroblast lineage). We propose that these changes increase the likelihood that inappropriately surviving cells are successfully incorporated into the embryo, rather than being extruded.
Vertebrate MELK may function in a general aspect of cell fate acquisition and its overexpression can promote tumorigenesis [3, 4, 9]; however, the underlying mechanism(s) are not fully understood. We demonstrate that by controlling actomyosin-dependent processes, C. elegans PIG-1 MELK affects daughter cell size asymmetry and partitioning of cell fate determinants during asymmetric cell division. This raises the question of whether vertebrate MELK affects cell fate acquisition by similarly controlling actomyosin-dependent processes during asymmetric cell division. Defects in asymmetric cell division have been shown to promote tumorigenesis in a number of cellular contexts [60]. Therefore, overexpression of MELK may promote tumorigenesis by causing defects in asymmetric cell division.
Methods
Strains and genetics
Unless noted otherwise, all C. elegans strains were maintained at 20°C as described [61]. Bristol N2 was used as the wild-type strain. Mutations and transgenes used are: LGI: ces-1(tm1036) (National BioResource Center) [28], ces-2(bc213) [25], nmy-2(ne3409ts) [62], nmy-2(cp13) (nmy-2::gfp+LoxP) [42], ced-1(e1735) [63]. LGII: mop-25.2(ok2073)/mIn1[mIs14 dpy-10(e128)] [64], bcSi66 (Pces-1ces-1::mNeonGreen) (this study), ltSi202 (Pspd-2gfp::spd-5) [65]. LGIII: strd-1(ok2283) [64], bcIs57 (Ppie-1gfp::phPLCδ) [25], bcIs66 (Ptph-1his-24::gfp) [28], bcSi96 (Pnmy-2nmy-2::mKate2) (this study), bcSi103 (Pnmy-2nmy-2S211D/S1974D::mKate2) (this study). LGIV: pig-1(gm344) [14], ced-3(n2427) [66], bcSi102 (Pnmy-2nmy-2S211D/S1974D::mKate2) (this study). LGV: par-4(it57ts) [67], ltIs44 (Ppie-1mCherry::phPLCδ) [68], bcIs37 (Pegl-1his-24::gfp) [34], bcSi97 (Pnmy-2nmy-2::mKate2) (this study), bcSi101 (Pnmy-2nmy-2S211A/S1974A::mKate2) (this study). LGX: bcSi99 (Pnmy-2nmy-2S211A/S1974A::mKate2) (this study), bcIs65 (Ptph-1his-24::gfp) (this study).
Molecular biology
Plasmid pBC1821 was generated using T4 ligation. Briefly, using the primer pairs ces-1 mNeonGreenF1 and ces-1 mNeonGreenR1, ces-1 mNeonGreenF2 and ces-1 mNeonGreenR2, and ces-1 mNeonGreenF3 and ces-1 mNeonGreenR3, three overlapping DNA fragments were generated and combined using the primer pair ces-1 mNeonGreenF1 and ces-1 mNeonGreenR3. The resulting DNA fragment was cloned into pBC1448 [27] using the restriction sites Sph I and Rsr II and T4 ligase to generate plasmid pBC1821 (Pces-1ces-1::mNeonGreen). Plasmids pBC1876 (Pnmy-2nmy-2), pBC1877 (Pnmy-2nmy-2S211AS1974A) and pBC1878 (Pnmy-2nmy-2S211DS1974D) were generated from plasmid pAC211 (Pnmy-2 5.2kbnmy-2re-encoded::mKate2::Streptag 3'UTRnmy-2 1.25kb in pCFJ151; a region of ∼400 bp in exon 12 of nmy-2 is re-encoded; mKate2::Streptag was added at the 3’ of the nmy-2 ORF; mKate2 was amplified from a plasmid that we received as a gift from Henrik Bringmann (University of Marburg)). Briefly, using Gibson cloning, plasmid pAC211 was used as template to mutate the codons of the nmy-2 coding region coding for S211 and S1974 to A211 and A1974 or D211 and D1974 using PCR with high fidelity fusion polymerase. The resulting fragments were digested with SmaI and cloned into pCFJ909 using Gibson ligation to generate pBC1876 (Pnmy-2nmy-2), pBC1877(Pnmy-2nmy-2S211A/S1974A) and pBC1878(Pnmy-2nmy-2S211D/S1974D).
Transgenic animals
Germline transformations were performed as described by Mello and Fire [69]. For the generation of the Pces-1ces-1::mNeonGreen mosSCI lines, plasmid pBC1821 was injected at a concentration of 40 ng/μl with co-injection markers (pCFJ601 at 50 ng/μl, pGH8 at 10 ng/μl, pCFJ90 at 2.5 ng/μl, pCFJ104 at 5 ng/μl) into the Universal MosSCI strain EG8079 [70] or mosSCI strain EG6699 [71] to acquire the integrated (single-copy) transgenes bcSi66 (Pces-1ces-1::mNeonGreen) and bcSi67 (Pces-1ces-1::mNeonGreen) on chromosome II. bcSi66 was chosen for analyses. For the generation of the Pnmy-2nmy-2::mKate2 miniMOS line, plasmid pBC1876 was injected at a concentration of 15 ng/μl with co-injection markers (pCFJ601 at 50 ng/μl, pGH8 at 10 ng/μl, pCFJ90 at 2.5 ng/μl, pCFJ104 at 5 ng/μl) into the miniMOS strain HT1593 [70]. Single-copy integrations on chromosome III (Pnmy-2nmy-2::mKate2, bcSi96 III) and chromosome V were obtained (Pnmy-2nmy-2::mKate2, bcSi97 V). To generate the Pnmy-2nmy-2S211AS1974A::mKate2 and Pnmy-2nmy-2S211DS1974D::mKate2 miniMOS lines, plasmids pBC1877 and pBC1878 were injected at a concentration of 10 ng/μl with co-injection markers (pCFJ601 at 50 ng/μl, pGH8 at 10 ng/μl, pCFJ90 at 2.5 ng/μl, pCFJ104 at 5 ng/μl) into the miniMOS strain HT1593 [70] and various single-copy integrations on different chromosomes were obtained (Pnmy-2nmy-2S211A/S1974A::mKate2, bcSi99 X, bcSi101 IV) (Pnmy-2nmy-2S211D/S1974D::mKate2, bcSi102 IV, bcSi103 III). For this study, bcSi97 (Pnmy-2nmy-2::mKate2), bcSi101 (Pnmy-2nmy-2S211A/S1974A::mKate2) and bcSi102 (Pnmy-2nmy-2S211D/S1974D::mKate2) were chosen for analyses. The miniMOS integration sites on different chromosomes were determined using inverse PCR [72].
Phenotypic analyses
NSMsc survival
The number of surviving NSMsc was determined in L3 or L4 larvae using the transgenes bcIs66 (Ptph-1his-24::gfp) or bcIs65 (Ptph-1his-24::gfp) as described [27, 28].
Quantification of cell volume ratio [NSMsc/NSM]
To estimate the volumes of the NSM and NSMsc, the transgenes Ppie-1gfp::phPLCδ (bcIs57) (par-4(it57ts) background) or Ppie-1mCherry::phPLCδ (ltIs44) (all other genetic backgrounds) were used to label cell boundaries. The cell volume of NSM and NSMsc was acquired and the cell volume ratio [NSMsc/NSM] determined as described [36]. Imaging was performed using a Leica TCS SP5-II confocal microscope with the laser power set to 13%.
Kinetics of NSMsc cell death
4D Nomarski microscopy was used to determine the time it takes individual NSMsc to die [73]. Briefly, recordings were started prior to NSMnb division and the NSMsc was tracked until it formed a refractile cell corpse essentially as described [27].
Quantification of Pegl-1his-24::gfp expression
The kinetics of egl-1 transcription in the NSMsc was determined using the transcriptional reporter Pegl-1his-24::gfp (bcIs37). Transgene Ppie-1mCherry::phPLCδ (ltIs44) was used to visualize the cell boundary of the NSMsc. The fluorescence intensity of Pegl-1his-24::gfp in the NSMsc was measured in the center Z-slice of a Z-stack of the NSMsc using Image J and divided by the area of that slice. Values for fluorescence intensity/area were normalized to the values at 0 min, which were set to 1. Imaging was performed using a Leica TCS SP5-II confocal microscope and the laser power for detecting Ppie-1mCherry::phPLCδ and Pegl-1his-24::gfp were set to 13% or 30%, respectively.
Quantification of Pces-1ces-1::mNeonGreen
The single-copy transgene Pces-1ces-1::mNeonGreen (bcSi66) was used to visualize CES-1 protein and the transgene Ppie-1mCherry::phPLCδ (ltIs44) was used to label cell boundaries. To detect CES-1::mNeonGreen in the NSMnb lineage, a laser power of 60% had to be used (Leica TCS SP5-II confocal microscope). Because of bleaching, recordings were done at three different time points (~5 min before NSMnb metaphase, at NSMnb metaphase and post NSMnb division). Maximum intensity projections of Z-stacks through the NSMnb, NSM or NSMsc were generated and used for analyses. Total fluorescence intensity/area at different points along the dorsal to ventral axis of the NSMnb (0–4.8 μM) was determined in overlapping 2 pixel-steps. Values obtained for a certain genotype were normalized to the value obtained for the most dorsal area (0.0 μM), which was set to 1. To determine the ratios of total fluorescence intensities in the ventral to dorsal half of the NSMnb, the NSMnb in the maximum intensity projection was divided into dorsal and ventral halves, the fluorescence intensities in the two halves measured, and the two values obtained divided [ventral/dorsal]. The same procedure was used to determine the ratios of total fluorescence intensities in the NSM to NSMsc [NSM/NSMsc].
Visualization and quantification of nmy-2::gfp+LoxP(cp13)
The CRISPR knock-in allele nmy-2(cp13) (nmy-2::gfp+LoxP) was used to visualize endogenous NMY-2 protein (green). Cell boundaries were labeled with transgene Ppie-1mCherry::phPLCδ (ltIs44) (magenta). For image acquisition, 25% laser power (Pnmy-2nmy-2::gfp) or 13% laser power (Ppie-1mCherry::phPLCδ) was used (Leica TCS SP5-II). All analyses were performed on center Z-slices of Z-stacks through the NSMnb. For determining fluorescence intensity/area at different points along the dorsal to ventral axis of the NSMnb (0–4.8 μM), we measured fluorescence intensity/area in overlapping 2 pixel-steps. Values obtained for a certain genotype were normalized to the value obtained at 2.4 μM, which was set to 1. To determine the ratios of fluorescence intensities in the ventral to dorsal half of the NSMnb, the NSMnb in the center Z-slice was divided into dorsal and ventral halves, the fluorescence intensity in the two halves were measured and the values obtained divided [ventral/dorsal].
Determination of the orientation of the NSMnb cleavage plane
The orientation of the NSMnb cleavage plane was analyzed using transgene Ppie-1mCherry::phPLCδ(ltIs44) (magenta), which labels cell boundaries, and transgene Pspd-2gfp::spd-5(ltSi202), which labels centrosomes (green), as described previously [27].
Quantification of embryonic lethality
Briefly, ~40–50 young adults of each genotype were dissected to acquire early-stage embryos. These embryos were transferred to slides with 2% agarose pads, cover slips were added and sealed with petroleum jelly and slides incubated at 25°C for ~7 h after which the viability of embryos was determined using light microscopy.
Confocal microscopy
Confocal imaging was done using a Leica TCS SP5-II confocal microscope. Different fusion proteins required different laser powers for imaging but for each fusion, the laser power was kept constant throughout the experiments. Strains were maintained at 15°C (temperature-sensitive alleles) or 20°C. Three hours prior to confocal recording, ~10 to 15 adults were dissected to acquire early-stage embryos. These embryos were transferred to slides with 2% agarose pads, cover slips were added and sealed with petroleum jelly, and slides incubated at 25°C. For recording of the NSMnb lineage, a Z-stack of 7.5–8.0 μm with a step distance of 0.5 μm was acquired.
RNA interference
mop-25.1 and mop-25.2 RNAi was done using the microinjection method as described [74]. mop-25.1 and mop-25.2 dsRNAs were both injected at a concentration of 100 ng/μl into mop-25.2(ok2073)/mIn1[mIs14 dpy-10(e128)] young adults. Injected adults were maintained at 25°C for ~22–24 h before imaging F1 embryos. For quantifying NSMsc survival of mop-25.2(ok2073)/mIn1[mIs14 dpy-10(e128)], injected mop-25.2(ok2073)/mIn1[mIs14 dpy-10(e128)] adults were removed after a ~24 h incubation period at 25°C and NSMsc survival was determined in F1 progeny once they had reached the L3 or L4 stage.
Handling of temperature-sensitive (ts) mutants
To image the NSMnb lineage in par-4(it57ts) animals, L4 larvae were picked, maintained at 25°C for 16 h and then transferred to 15°C overnight [23]. Early stage embryos were acquired by dissecting the resulting adults, incubating the embryos at 20°C for 1 h and subsequently at 25°C for 1 h until they had reached the early comma stage. For determining NSMsc survival in the par-4(it57ts) background, L4 larvae were incubated at 25°C for ~20 h and shifted to 20°C for another ~16 h to let them lay F1 embryos. The P0 adults were removed and NSMsc survival determined in F1 animals, once they had reached the L3 or L4 stage at 15°C. To image the NSMnb lineage in nmy-2(ne3409ts) animals, adults were maintained at 15°C, early stage F1 embryos were acquired by dissecting P0 adults, incubated at 15°C for 1 h, at 20°C for 45 min, and at 25°C for ~15 min before confocal imaging. For determining NSMsc survival rate in nmy-2(ne3409ts) animals, L4 larvae were picked and maintained at 15°C overnight. The following day, the young P0 adults were shifted to 25°C for 10 min and transferred back to 15°C for 40 min. These temperature shifts were repeated for ~9 to 10 h after which the P0 animals were removed. The F1 embryos were allowed to develop to the L3 or L4 stage at 15°C and subsequently analyzed.
Supporting information
S1 Fig [left]
Daughter cell sizes in the NSM neuroblast lineage.
S2 Fig [tif]
Kinetics of the NSM sister cell death.
S3 Fig [gm344]
Kinetics of upregulation of expression in the NSM sister cell.
S4 Fig [a]
P:: rescues polarity defect of Snail loss-of-function (lf) mutant.
S5 Fig [a]
Kinetics of asymmetric enrichment of nonmuscle myosin NMY-2 in the NSM neuroblast.
S6 Fig [a]
Total amount of endogenous NMY-2::GFP.
S7 Fig [s]
Phosphorylation at residues S211 and S1974 is critical for the ability of nonmuscle myosin NMY-2 to promote embryonic viability.
S8 Fig [a]
Phosphorylation at residues S211 and S1974 is critical for the ability of nonmuscle myosin NMY-2 to control daughter cell size in the NSM neuroblast lineage.
S1 Data [xlsx]
Numerical data presented in figures.
Zdroje
1. Heyer BS, Warsowe J, Solter D, Knowles BB, Ackerman SL. New member of the Snf1/AMPK kinase family, Melk, is expressed in the mouse egg and preimplantation embryo. Mol Reprod Dev. 1997;47(2):148–56. doi: 10.1002/(SICI)1098-2795(199706)47:2<148::AID-MRD4>3.0.CO;2-M 9136115.
2. Gil M, Yang Y, Lee Y, Choi I, Ha H. Cloning and expression of a cDNA encoding a novel protein serine/threonine kinase predominantly expressed in hematopoietic cells. Gene. 1997;195(2):295–301. doi: 10.1016/s0378-1119(97)00181-9 9305775.
3. Ganguly R, Mohyeldin A, Thiel J, Kornblum HI, Beullens M, Nakano I. MELK-a conserved kinase: functions, signaling, cancer, and controversy. Clin Transl Med. 2015;4:11. doi: 10.1186/s40169-014-0045-y 25852826; PubMed Central PMCID: PMC4385133.
4. Jiang P, Zhang D. Maternal embryonic leucine zipper kinase (MELK): a novel regulator in cell cycle control, embryonic development, and cancer. Int J Mol Sci. 2013;14(11):21551–60. doi: 10.3390/ijms141121551 24185907; PubMed Central PMCID: PMC3856021.
5. Perry NA, Fialkowski KP, Kaoud TS, Kaya AI, Chen AL, Taliaferro JM, et al. Arrestin-3 interaction with maternal embryonic leucine-zipper kinase. Cell Signal. 2019;63:109366. doi: 10.1016/j.cellsig.2019.109366 31352007; PubMed Central PMCID: PMC6717526.
6. Beullens M, Vancauwenbergh S, Morrice N, Derua R, Ceulemans H, Waelkens E, et al. Substrate specificity and activity regulation of protein kinase MELK. J Biol Chem. 2005;280(48):40003–11. doi: 10.1074/jbc.M507274200 16216881.
7. Joshi K, Banasavadi-Siddegowda Y, Mo X, Kim SH, Mao P, Kig C, et al. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells. Stem Cells. 2013;31(6):1051–63. doi: 10.1002/stem.1358 23404835; PubMed Central PMCID: PMC3744761.
8. Wang Y, Begley M, Li Q, Huang HT, Lako A, Eck MJ, et al. Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival. Proc Natl Acad Sci U S A. 2016;113(35):9810–5. doi: 10.1073/pnas.1606862113 27528663; PubMed Central PMCID: PMC5024598.
9. Pitner MK, Taliaferro JM, Dalby KN, Bartholomeusz C. MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies. Expert Opin Ther Targets. 2017;21(9):849–59. doi: 10.1080/14728222.2017.1363183 28764577.
10. Lin A, Giuliano CJ, Sayles NM, Sheltzer JM. CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials. Elife. 2017;6. doi: 10.7554/eLife.24179 28337968; PubMed Central PMCID: PMC5365317.
11. Toure BB, Giraldes J, Smith T, Sprague ER, Wang Y, Mathieu S, et al. Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight. J Med Chem. 2016;59(10):4711–23. doi: 10.1021/acs.jmedchem.6b00052 27187609.
12. Wang Y, Lee YM, Baitsch L, Huang A, Xiang Y, Tong H, et al. MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. Elife. 2014;3:e01763. doi: 10.7554/eLife.01763 24844244; PubMed Central PMCID: PMC4059381.
13. Wang Y, Li BB, Li J, Roberts TM, Zhao JJ. A Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer Cells. iScience. 2018;9:149–60. doi: 10.1016/j.isci.2018.10.015 30391850; PubMed Central PMCID: PMC6215964.
14. Cordes S, Frank CA, Garriga G. The C. elegans MELK ortholog PIG-1 regulates cell size asymmetry and daughter cell fate in asymmetric neuroblast divisions. Development. 2006;133(14):2747–56. doi: 10.1242/dev.02447 16774992.
15. Sulston JE, Schierenberg E, White JG, Thomson JN. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol. 1983;100(1):64–119. doi: 10.1016/0012-1606(83)90201-4 6684600
16. Liro MJ, Morton DG, Rose LS. The kinases PIG-1 and PAR-1 act in redundant pathways to regulate asymmetric division in the EMS blastomere of C. elegans. Dev Biol. 2018;444(1):9–19. doi: 10.1016/j.ydbio.2018.08.016 30213539; PubMed Central PMCID: PMC6238631.
17. Morton DG, Hoose WA, Kemphues KJ. A genome-wide RNAi screen for enhancers of par mutants reveals new contributors to early embryonic polarity in Caenorhabditis elegans. Genetics. 2012;192(3):929–42. doi: 10.1534/genetics.112.143727 22887819; PubMed Central PMCID: PMC3522167.
18. Pacquelet A, Uhart P, Tassan JP, Michaux G. PAR-4 and anillin regulate myosin to coordinate spindle and furrow position during asymmetric division. J Cell Biol. 2015;210(7):1085–99. doi: 10.1083/jcb.201503006 26416962; PubMed Central PMCID: PMC4586735.
19. Ou G, Stuurman N, D'Ambrosio M, Vale RD. Polarized myosin produces unequal-size daughters during asymmetric cell division. Science. 2010;330(6004):677–80. doi: 10.1126/science.1196112 20929735; PubMed Central PMCID: PMC3032534.
20. Denning DP, Hatch V, Horvitz HR. Programmed elimination of cells by caspase-independent cell extrusion in C. elegans. Nature. 2012;488(7410):226–30. doi: 10.1038/nature11240 22801495; PubMed Central PMCID: PMC3416925.
21. Hirose T, Horvitz HR. An Sp1 transcription factor coordinates caspase-dependent and -independent apoptotic pathways. Nature. 2013;500(7462):354–8. doi: 10.1038/nature12329 23851392; PubMed Central PMCID: PMC3748152.
22. Alessi DR, Sakamoto K, Bayascas JR. LKB1-dependent signaling pathways. Annu Rev Biochem. 2006;75:137–63. doi: 10.1146/annurev.biochem.75.103004.142702 16756488.
23. Chien SC, Brinkmann EM, Teuliere J, Garriga G. Caenorhabditis elegans PIG-1/MELK Acts in a Conserved PAR-4/LKB1 Polarity Pathway to Promote Asymmetric Neuroblast Divisions. Genetics. 2013;193(3):897–909. doi: 10.1534/genetics.112.148106 23267054; PubMed Central PMCID: PMC3584005.
24. Ellis RE, Horvitz HR. Two C. elegans genes control the programmed deaths of specific cells in the pharynx. Development. 1991;112(2):591–603. 1794327
25. Hatzold J, Conradt B. Control of apoptosis by asymmetric cell division. PLoS Biol. 2008;6(4):e84. Epub 2008/04/11. 07-PLBI-RA-2604 [pii] doi: 10.1371/journal.pbio.0060084 18399720; PubMed Central PMCID: PMC2288629.
26. Metzstein MM, Horvitz HR. The C. elegans cell death specification gene ces-1 encodes a snail family zinc finger protein. Mol Cell. 1999;4(3):309–19. doi: 10.1016/s1097-2765(00)80333-0 10518212
27. Wei H, Yan B, Gagneur J, Conradt B. Caenorhabditis elegans CES-1 Snail Represses pig-1 MELK Expression To Control Asymmetric Cell Division. Genetics. 2017;206(4):2069–84. doi: 10.1534/genetics.117.202754 28652378; PubMed Central PMCID: PMC5560807.
28. Yan B, Memar N, Gallinger J, Conradt B. Coordination of cell proliferation and cell fate determination by CES-1 snail. PLoS Genet. 2013;9(10):e1003884. doi: 10.1371/journal.pgen.1003884 24204299; PubMed Central PMCID: PMC3814331.
29. Sulston JE, Horvitz HR. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol. 1977;56(1):110–56. doi: 10.1016/0012-1606(77)90158-0 838129
30. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elegans. Cell. 1986;44(6):817–29. doi: 10.1016/0092-8674(86)90004-8 3955651
31. Conradt B, Horvitz HR. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell. 1998;93(4):519–29. doi: 10.1016/s0092-8674(00)81182-4 9604928.
32. Conradt B, Horvitz HR. The TRA-1A sex determination protein of C. elegans regulates sexually dimorphic cell deaths by repressing the egl-1 cell death activator gene. Cell. 1999;98(3):317–27. doi: 10.1016/s0092-8674(00)81961-3 10458607.
33. Horvitz HR. Worms, life, and death (Nobel lecture). Chembiochem. 2003;4(8):697–711. doi: 10.1002/cbic.200300614 12898619.
34. Thellmann M, Hatzold J, Conradt B. The Snail-like CES-1 protein of C. elegans can block the expression of the BH3-only cell-death activator gene egl-1 by antagonizing the function of bHLH proteins. Development. 2003;130(17):4057–71. doi: 10.1242/dev.00597 12874127.
35. Metzstein MM, Hengartner MO, Tsung N, Ellis RE, Horvitz HR. Transcriptional regulator of programmed cell death encoded by Caenorhabditis elegans gene ces-2. Nature. 1996;382(6591):545–7. doi: 10.1038/382545a0 8700229
36. Chakraborty S, Lambie EJ, Bindu S, Mikeladze-Dvali T, Conradt B. Engulfment pathways promote programmed cell death by enhancing the unequal segregation of apoptotic potential. Nat Commun. 2015;6:10126. doi: 10.1038/ncomms10126 26657541; PubMed Central PMCID: PMC4682117.
37. Lambie EJ, Conradt B. Deadly dowry: how engulfment pathways promote cell killing. Cell Death Differ. 2016;23(4):553–4. doi: 10.1038/cdd.2015.170 26868911; PubMed Central PMCID: PMC4986643.
38. Mishra N, Wei H, Conradt B. Caenorhabditis elegans ced-3 Caspase Is Required for Asymmetric Divisions That Generate Cells Programmed To Die. Genetics. 2018;210(3):983–98. doi: 10.1534/genetics.118.301500 30194072; PubMed Central PMCID: PMC6218217.
39. Zhou Z, Hartwieg E, Horvitz HR. CED-1 is a transmembrane receptor that mediates cell corpse engulfment in C. elegans. Cell. 2001;104(1):43–56. doi: 10.1016/s0092-8674(01)00190-8 11163239
40. Guo S, Kemphues KJ. A non-muscle myosin required for embryonic polarity in Caenorhabditis elegans. Nature. 1996;382(6590):455–8. doi: 10.1038/382455a0 8684486.
41. Offenburger SL, Bensaddek D, Murillo AB, Lamond AI, Gartner A. Comparative genetic, proteomic and phosphoproteomic analysis of C. elegans embryos with a focus on ham-1/STOX and pig-1/MELK in dopaminergic neuron development. Sci Rep. 2017;7(1):4314. doi: 10.1038/s41598-017-04375-4 28659600; PubMed Central PMCID: PMC5489525.
42. Dickinson DJ, Ward JD, Reiner DJ, Goldstein B. Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat Methods. 2013;10(10):1028–34. doi: 10.1038/nmeth.2641 23995389; PubMed Central PMCID: PMC3905680.
43. Chugh P, Paluch EK. The actin cortex at a glance. J Cell Sci. 2018;131(14). doi: 10.1242/jcs.186254 30026344; PubMed Central PMCID: PMC6080608.
44. Hoege C, Hyman AA. Principles of PAR polarity in Caenorhabditis elegans embryos. Nat Rev Mol Cell Biol. 2013;14(5):315–22. doi: 10.1038/nrm3558 23594951.
45. Illukkumbura R, Bland T, Goehring NW. Patterning and polarization of cells by intracellular flows. Curr Opin Cell Biol. 2020;62:123–34. doi: 10.1016/j.ceb.2019.10.005 31760155; PubMed Central PMCID: PMC6968950.
46. Rose L, Gonczy P. Polarity establishment, asymmetric division and segregation of fate determinants in early C. elegans embryos. WormBook. 2014:1–43. doi: 10.1895/wormbook.1.30.2 25548889.
47. Cheeks RJ, Canman JC, Gabriel WN, Meyer N, Strome S, Goldstein B. C. elegans PAR proteins function by mobilizing and stabilizing asymmetrically localized protein complexes. Curr Biol. 2004;14(10):851–62. doi: 10.1016/j.cub.2004.05.022 15186741.
48. Folkmann AW, Seydoux G. Single-molecule study reveals the frenetic lives of proteins in gradients. Proc Natl Acad Sci U S A. 2018;115(38):9336–8. doi: 10.1073/pnas.1812248115 30181287; PubMed Central PMCID: PMC6156616.
49. Goehring NW, Trong PK, Bois JS, Chowdhury D, Nicola EM, Hyman AA, et al. Polarization of PAR proteins by advective triggering of a pattern-forming system. Science. 2011;334(6059):1137–41. doi: 10.1126/science.1208619 22021673.
50. Munro E, Nance J, Priess JR. Cortical flows powered by asymmetrical contraction transport PAR proteins to establish and maintain anterior-posterior polarity in the early C. elegans embryo. Dev Cell. 2004;7(3):413–24. doi: 10.1016/j.devcel.2004.08.001 15363415.
51. Peglion F, Goehring NW. Switching states: dynamic remodelling of polarity complexes as a toolkit for cell polarization. Curr Opin Cell Biol. 2019;60:121–30. doi: 10.1016/j.ceb.2019.05.002 31295650; PubMed Central PMCID: PMC6906085.
52. Wu Y, Han B, Li Y, Munro E, Odde DJ, Griffin EE. Rapid diffusion-state switching underlies stable cytoplasmic gradients in the Caenorhabditis elegans zygote. Proc Natl Acad Sci U S A. 2018;115(36):E8440–E9. doi: 10.1073/pnas.1722162115 30042214; PubMed Central PMCID: PMC6130366.
53. Loyer N, Januschke J. Where does asymmetry come from? Illustrating principles of polarity and asymmetry establishment in Drosophila neuroblasts. Curr Opin Cell Biol. 2020;62:70–7. doi: 10.1016/j.ceb.2019.07.018 31698250.
54. Tsankova A, Pham TT, Garcia DS, Otte F, Cabernard C. Cell Polarity Regulates Biased Myosin Activity and Dynamics during Asymmetric Cell Division via Drosophila Rho Kinase and Protein Kinase N. Dev Cell. 2017;42(2):143–55 e5. doi: 10.1016/j.devcel.2017.06.012 28712722.
55. Cabernard C, Prehoda KE, Doe CQ. A spindle-independent cleavage furrow positioning pathway. Nature. 2010;467(7311):91–4. doi: 10.1038/nature09334 20811457; PubMed Central PMCID: PMC4028831.
56. Connell M, Cabernard C, Ricketson D, Doe CQ, Prehoda KE. Asymmetric cortical extension shifts cleavage furrow position in Drosophila neuroblasts. Mol Biol Cell. 2011;22(22):4220–6. doi: 10.1091/mbc.E11-02-0173 21937716; PubMed Central PMCID: PMC3216648.
57. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002;3(3):155–66. doi: 10.1038/nrm757 11994736.
58. Amoyel M. Gut stem cells, a story of snails, flies and mice. EMBO J. 2015;34(10):1287–9. doi: 10.15252/embj.201591541 25863942; PubMed Central PMCID: PMC4491989.
59. Goossens S, Vandamme N, Van Vlierberghe P, Berx G. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET. Biochim Biophys Acta Rev Cancer. 2017;1868(2):584–91. doi: 10.1016/j.bbcan.2017.06.006 28669750.
60. Knoblich JA. Asymmetric cell division: recent developments and their implications for tumour biology. Nat Rev Mol Cell Biol. 2010;11(12):849–60. doi: 10.1038/nrm3010 21102610; PubMed Central PMCID: PMC3941022.
61. Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94. 4366476
62. Liu J, Maduzia LL, Shirayama M, Mello CC. NMY-2 maintains cellular asymmetry and cell boundaries, and promotes a SRC-dependent asymmetric cell division. Dev Biol. 2010;339(2):366–73. doi: 10.1016/j.ydbio.2009.12.041 20059995; PubMed Central PMCID: PMC2903000.
63. Hedgecock EM, Sulston JE, Thomson JN. Mutations affecting programmed cell deaths in the nematode Caenorhabditis elegans. Science. 1983;220(4603):1277–9. doi: 10.1126/science.6857247 6857247
64. Consortium CeDM. large-scale screening for targeted knockouts in the Caenorhabditis elegans genome. G3 (Bethesda). 2012;2(11):1415–25. doi: 10.1534/g3.112.003830 23173093; PubMed Central PMCID: PMC3484672.
65. Wueseke O, Zwicker D, Schwager A, Wong YL, Oegema K, Julicher F, et al. Polo-like kinase phosphorylation determines Caenorhabditis elegans centrosome size and density by biasing SPD-5 toward an assembly-competent conformation. Biol Open. 2016;5(10):1431–40. doi: 10.1242/bio.020990 27591191; PubMed Central PMCID: PMC5087692.
66. Shaham S, Reddien PW, Davies B, Horvitz HR. Mutational analysis of the Caenorhabditis elegans cell-death gene ced-3. Genetics. 1999;153(4):1655–71. 10581274
67. Morton DG, Roos JM, Kemphues KJ. par-4, a gene required for cytoplasmic localization and determination of specific cell types in Caenorhabditis elegans embryogenesis. Genetics. 1992;130(4):771–90. 1582558; PubMed Central PMCID: PMC1204928.
68. Audhya A, Hyndman F, McLeod IX, Maddox AS, Yates JR, 3rd, Desai A, et al. A complex containing the Sm protein CAR-1 and the RNA helicase CGH-1 is required for embryonic cytokinesis in Caenorhabditis elegans. J Cell Biol. 2005;171(2):267–79. doi: 10.1083/jcb.200506124 16247027.
69. Mello C, Fire A. DNA transformation. Methods Cell Biol. 1995;48:451–82. 8531738
70. Frokjaer-Jensen C, Davis MW, Sarov M, Taylor J, Flibotte S, LaBella M, et al. Random and targeted transgene insertion in Caenorhabditis elegans using a modified Mos1 transposon. Nat Methods. 2014;11(5):529–34. doi: 10.1038/nmeth.2889 24820376; PubMed Central PMCID: PMC4126194.
71. Frokjaer-Jensen C, Davis MW, Ailion M, Jorgensen EM. Improved Mos1-mediated transgenesis in C. elegans. Nat Methods. 2012;9(2):117–8. doi: 10.1038/nmeth.1865 22290181; PubMed Central PMCID: PMC3725292.
72. Boulin T, Bessereau JL. Mos1-mediated insertional mutagenesis in Caenorhabditis elegans. Nat Protoc. 2007;2(5):1276–87. doi: 10.1038/nprot.2007.192 17546024.
73. Schnabel R, Hutter H, Moerman D, Schnabel H. Assessing normal embryogenesis in Caenorhabditis elegans using a 4D microscope: variability of development and regional specification. Dev Biol. 1997;184(2):234–65. doi: 10.1006/dbio.1997.8509 9133433
74. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669):806–11. Epub 1998/03/05. doi: 10.1038/35888 9486653.
Článek vyšel v časopise
PLOS Genetics
2020 Číslo 9
- Antibiotika na nachlazení nezabírají! Jak můžeme zpomalit šíření rezistence?
- FDA varuje před selfmonitoringem cukru pomocí chytrých hodinek. Jak je to v Česku?
- Prof. Jan Škrha: Metformin je bezpečný, ale je třeba jej bezpečně užívat a léčbu kontrolovat
- Ibuprofen jako alternativa antibiotik při léčbě infekcí močových cest
- Jak a kdy u celiakie začíná reakce na lepek? Možnou odpověď poodkryla čerstvá kanadská studie
Nejčtenější v tomto čísle
- Alleviating chronic ER stress by p38-Ire1-Xbp1 pathway and insulin-associated autophagy in C. elegans neurons
- Cocoonase is indispensable for Lepidoptera insects breaking the sealed cocoon
- A mega-analysis of expression quantitative trait loci in retinal tissue
- Adiponectin GWAS loci harboring extensive allelic heterogeneity exhibit distinct molecular consequences